GlassScriptPhysician profile
Catherynne Morgan
NPI 1346444148
$2,893.56
in general payments reported to CMS, 2019-2025
19 companies · $380 in 2025
The $380 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.10 · 2022: $392 · 2023: $818 · 2024: $1,289 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,486.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $962.78 | 2022-2025 | Stelara, Simponi, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $425.54 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Abbvie INC. | $416.21 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $228.76 | 2022-2024 | Dupixent |
| Ardelyx, INC. | $162.89 | 2023-2025 | Ibsrela |
| Genzyme Corporation | $142.96 | 2022-2024 | |
| Braintree Laboratories, INC. | $86.44 | 2022-2025 | Sutab, Suflave |
| Alnylam Pharmaceuticals INC. | $79.21 | 2023 | Givlaari |
| Madrigal Pharmaceuticals | $68.11 | 2024-2025 | Rezdiffra, Resmetirom |
| E.R. Squibb & Sons, L.L.C. | $61.60 | 2022 | |
| Intercept Pharmaceuticals, INC. | $57.39 | 2023-2025 | Ocaliva |
| Phathom Pharmaceuticals, INC. | $44.94 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.14 | 2019-2023 | Xifaxan |
| Redhill Biopharma INC. | $27.02 | 2022-2024 | Talicia |
| Celltrion USA INC. | $22.86 | 2024 | Vegzelma |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $20.36 | 2024 | |
| Qol Medical, LLC | $19.52 | 2022 | |
| Nestle Healthcare Nutrition INC. | $15.03 | 2023 | |
| Oxford Immunotec USA INC | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherynne Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.